Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Vaishali Pharma's Days Inventory or its related term are showing as below:
NSE:VAISHALI's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 164.8 * Ranked among companies with meaningful Days Inventory only.
Vaishali Pharma's Days Inventory
increased
from Mar. 2024 (1.07) to Mar. 2025 (14.32).
It might indicate that Vaishali Pharma's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vaishali Pharma's Inventory Turnover for the
three
months ended in Mar. 2025 was 6.37.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vaishali Pharma's Inventory-to-Revenue for the
three
months ended in Mar. 2025 was 0.15.
Vaishali Pharma (NSE:VAISHALI) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vaishali Pharma's Inventory Turnover for the
three
months ended in Mar. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vaishali Pharma's Inventory to Revenue for the
three
months ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vaishali Pharma Days Inventory Related Terms
Vaishali Pharma Days Inventory Historical Data
* Premium members only.
The historical data trend for Vaishali Pharma's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vaishali Pharma's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vaishali Pharma Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vaishali Pharma's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vaishali Pharma's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaishali Pharma (NSE:VAISHALI) has a Days Inventory of 14.32 as of Mar. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vaishali Pharma and its competitors.
Is Vaishali Pharma's Days Inventory too high?
Vaishali Pharma's current Days Inventory is 14.32. The Drug Manufacturers industry median Days Inventory is 164.80. Vaishali Pharma's value of 14.32 is 91.3% below this industry median. Overall, Vaishali Pharma has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Vaishali Pharma's Days Inventory compare to ZTS?
Vaishali Pharma's Days Inventory of 14.32 can be compared against companies in the Drug Manufacturers industry. The industry median Days Inventory is 164.80. Vaishali Pharma's value of 14.32 is 91.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.80, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vaishali Pharma's current Days Inventory of 14.32 is 91.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vaishali Pharma and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vaishali Pharma's current Days Inventory is 14.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaishali Pharma stock overvalued right now?
Vaishali Pharma (NSE:VAISHALI) has a current Days Inventory of 14.32. The current Days Inventory is 14.32 and 91.3% below the Drug Manufacturers industry median of 164.80. Vaishali Pharma's overall GF Score™ is 52/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vaishali Pharma (NSE:VAISHALI), the current Days Inventory is 14.32 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vaishali Pharma Ltd is a pharmaceutical company. The Company is engaged in the marketing of pharmaceutical products including active pharmaceutical ingredients.
52GF Score
Get the complete analysis for NSE:VAISHALI
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:VAISHALI has been successfully added to your 
